Table 6.

Interaction between treatment type (GPNC versus IPNC) and race and ethnicity for serum inflammatory markers and placental inflammation

		Modified Intent-to-Treat (mITT)		Median or more visits in assigned treatment group (M+)
		Estimate (95% CL)	p-value	Estimate (95% CL)	p-value
Composite inflammatory score in 2nd trimester	Black Hispanic/Latine White	−0.15 (−0.95 – 0.66) 0.06 (−0.94 – 1.06) −0.42 (−1.24 – 0.41)	0.72 0.91 0.32	0.08 (−0.99 – 1.15) 0.26 (−0.89 – 1.41) −0.10 (−1.12 – 0.93)	0.88 0.66 0.85
Composite inflammatory score in 3rd trimester	Black Hispanic/Latine White	0.19 (−0.52 – 0.91) 1.17 (0.31 – 2.03) 0.15 (−0.57 – 0.86)	0.59 0.01 0.68	−0.20 (−1.11 – 0.71) 1.24 (0.24 – 2.24) 0.02 (−0.88 – 0.92)	0.66 0.02 0.96
		aOR (95% CL)	p-value	aOR (95% CL)	p-value
Maternal Acute or Chronic Inflammatory Lesions	Black Hispanic/Latine White	1.22 (0.75 – 2.00) 1.14 (0.61 – 2.11) 1.35 (0.86 – 2.11)	0.43 0.68 0.19	1.30 (0.70 – 2.41) 1.31 (0.62 – 2.79) 1.35 (0.79 – 2.32)	0.41 0.49 0.27

Adjusted for age, BMI, smoking before pregnancy, GA at blood draw

Bolded results indicate p<0.05